Net sales by business area

  3 months ending   12 months ending
SEKm 31 Mar 24 % 31 Mar 23   31 Mar 24 31 Dec 23
Labtech 863 -5 905   3,612 3,654
Medtech 1,708 10 1,554   6,196 6,042
Group items -1   -2   -10 -11
AddLife Group 2,570 5 2,457   9,798 9,685

 EBITA and EBITA-margin by business area and operating profit for the group

  3 months ending 12 months ending
SEKm 31 Mar 24 % 31 Mar 23 % 31 Mar 24 % 31 Dec 23 %
Labtech 99 11.5 115 12.7 457 12.6 473 12.9
Medtech 198 11.6 256 16.5 626 10.1 684 11.3
Parent Company and Group items -6   -5   -23   -22  
EBITA 291 11.3 366 14.9 1,060 10.8 1,135 11.7
Depreciation and write-down intangible assets -105   -108   -547   -550  
Operating profit 186 7.3 258 10.5 513 5.2 585 6.0
Finance income and expenses -86   -52   -280   -246  
Profit after financial items 100   206   233   339  

Net sales by revenue type

  3 months ending 12 months ending
SEKm 31 Mar 24 31 Mar 23 31 Mar 24 31 Dec 23
Products 620 653 2,515 2,548
Instruments 164 181 787 804
Service 79 71 310 302
Labtech 863 905 3,612 3,654
Products 1,299 1,265 4,946 4,912
Instruments 242 157 590 505
Service 167 132 660 625
Medtech 1,708 1,554 6,196 6,042
Group items -1 -2 -10 -11
Total 2,570 2,457 9,798 9,685

Sales per country

  3 months ending 12 months ending
  31 Mar 24 31 Mar 23 31 Mar 24 31 Dec 23
UK 400 299 1,287 1,186
Ireland 342 305 1,151 1,114
Sweden 276 298 1,078 1,100
Spain 232 213 845 826
Denmark 161 173 781 793
Norway 200 208 776 784
Italy 157 157 662 662
Finland 131 145 563 577
Rest of Europe 567 587 2,331 2,351
Rest of the world 104 72 324 292
Total 2,570 2,457 9,798 9,685

 

 

Latest updated: 2/9/2024 6:21:49 PM by Alexander Paziraei
NEXT